Antineoplastic agents (BASKET)

LE WE PMID CA

Antineoplastic agents (BASKET)

4229

Antineoplastische Substanz (allg)

2009 1	Disulfide and multisulfide antitumor agents and their modes of action. [19387571] Arch Pharm Res 32(3): 299-315 (2009)
2009 2	How do anti-mitotic drugs kill cancer cells? [19625502] J Cell Sci 122(Pt 15): 2579-85 (2009)
2008 3	Cardiac glycosides as novel cancer therapeutic agents. [18332483] Mol Interv 8(1): 36-49 (2008)
2008 4	Oncogenic ras-induced expression of cytokines: a new target of anti-cancer therapeutics. [18332481] Mol Interv 8(1): 22-7 (2008)
2009 5	New hopes from old drugs: revisiting DNA-binding small molecules as anticancer agents. [20001804] Future Oncol 5(10): 1685-704 (2009)
2009 6	Targeting mitotic fragility in cancer. [19519201] Future Oncol 5(5): 613-5 (2009)
1998 7	New antimetabolites in cancer chemotherapy and their clinical impact. [9717984] Br J Cancer 78 Suppl 3(-): 1-7 (1998)
2009 8	Novel agents on the horizon for cancer therapy. [19278961] CA Cancer J Clin 59(2): 111-37 (2009)
2008 9	Newer cytotoxic agents: attacking cancer broadly. [18347161] Clin Cancer Res 14(6): 1610-7 (2008)
2000 10	Mitochondrion as a novel target of anticancer chemotherapy. [10880547] J Natl Cancer Inst 92(13): 1042-53 (2000)
1963 11	Patterns of response of animal tumors to anticancer agents. A systematic analysis of the literature in experimental cancer chemotherapy--1945-1958. [5339901] Cancer Res 23(5 Pt 2): 521-980 (1963)
1957 12	The employment of combinations of drugs in the chemotherapy of neoplasia: a review. [13460966] Cancer Res 17(7): 635-54 (1957)
1957 13	Combination therapy of malignant tumors with ionizing radiations and chemicals; a review. [13446840] Cancer Res 17(6): 551-66 (1957)
1953 14	A review: on the mechanism of action of certain temporary anti-cancer agents. [13082484] Cancer Res 13(8): 545-51 (1953)
1998 15	Benefits of pharmacological knowledge in the design and monitoring of cancer chemotherapy. [9761935] Pathol Oncol Res 4(3): 171-8 (1998)
2003 16	Classical chemotherapy: mechanisms, toxicities and the therapeutic window. [14508075] Cancer Biol Ther 2(4 Suppl 1): S2-4 (2003)
2006 17	Recent developments in the clinical pharmacology of classical cytotoxic chemotherapy. [16842376] Br J Clin Pharmacol 62(1): 27-34 (2006)
2006 18	Drug development in oncology: classical cytotoxics and molecularly targeted agents. [16842375] Br J Clin Pharmacol 62(1): 15-26 (2006)
2010 19	Targeted delivery of microbubbles and nanobubbles for image-guided thermal ablation therapy of tumors. [20420552] Expert Rev Med Devices 7(3): 303-6 (2010)
2009 20	Recent advances in the development of polyamine analogues as antitumor agents. [19534534] J Med Chem 52(15): 4551-73 (2009)
2010 21	Dissecting variability in responses to cancer chemotherapy through systems pharmacology. [20520606] Clin Pharmacol Ther 88(1): 34-8 (2010)
2008 22	Role of mTOR in anticancer drug resistance: perspectives for improved drug treatment. [18440854] Drug Resist Updat 11(3): 63-76 (2008)
2010 23	Chemotherapy agents: a primer for the interventional radiologist. [22550380] Semin Intervent Radiol 27(4): 384-90 (2010)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Antineoplastic agents (BASKET).php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Antineoplastic agents (BASKET).php on line 92